Galectin Therapeutics (GALT) Stock Chart & Stock Price History $2.85 +0.05 (+1.79%) Closing price 04:00 PM EasternExtended Trading$2.85 0.00 (0.00%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galectin Therapeutics Stock Price Performance The Galectin Therapeutics (GALT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 13.10%, with a year-to-date return of 120.93%. In the past month, the stock has increased 91.28%, reflecting recent market activity. As of the latest close, Galectin Therapeutics traded at $2.80 with a market cap of $177.22 million and volume of 406,858 shares. Five years ago, the stock traded at $2.78, representing a 2.52% increase over that period. At the time, it had a market cap of $162.54 million and a volume of 136,300 shares. Receive GALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+13.55%1 Month Performance+91.28%3 Month Performance+108.03%Year-To-Date Performance+120.93%1 Year Performance+13.10%5 Year Performance+2.52% GALT Stock Chart for Wednesday, July, 16, 2025 GALT Chart by TradingView Galectin Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$2.85$2.80-1.75%$2.97$2.79406,858 shs$177.22 million07/14/2025$2.51$2.85+13.55%$2.85$2.51504,866 shs$180.38 million07/11/2025$2.45$2.51+2.45%$2.64$2.43391,063 shs$158.86 million07/10/2025$2.25$2.45+8.89%$2.49$2.18459,022 shs$155.06 million07/09/2025$2.09$2.25+7.66%$2.25$2.13259,127 shs$142.40 million07/08/2025$2.15$2.09-2.79%$2.19$2.07206,406 shs$132.28 million07/07/2025$2.16$2.15-0.23%$2.36$2.08468,292 shs$136.07 million07/04/2025$2.16$2.16$2.24$2.13239,497 shs$136.39 million07/03/2025$2.17$2.16-0.69%$2.24$2.13239,497 shs$136.39 million07/02/2025$2.22$2.17-2.25%$2.26$2.08271,287 shs$137.34 million Get the Latest News and Ratings for GALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$2.11$2.22+5.21%$2.27$2.10446,212 shs$140.50 million06/30/2025$2.33$2.11-9.44%$2.59$2.11455,660 shs$133.54 million06/27/2025$2.35$2.33-0.85%$2.63$2.301.95 million shs$147.47 million06/26/2025$2.51$2.35-6.37%$2.66$2.34497,877 shs$148.74 million06/25/2025$2.42$2.51+3.72%$2.63$2.43292,350 shs$158.86 million06/24/2025$2.48$2.42-2.42%$2.64$2.21543,423 shs$153.16 million06/23/2025$2.42$2.48+2.48%$2.80$2.25975,728 shs$156.96 million06/20/2025$3.29$2.42-26.44%$3.90$1.854.32 million shs$153.16 million06/19/2025$3.29$3.29$3.30$2.315.37 million shs$208.22 million06/18/2025$2.39$3.29+37.66%$3.30$2.315.37 million shs$208.22 million06/17/2025$1.49$2.39+60.40%$2.79$1.5411.56 million shs$151.27 million06/16/2025$1.37$1.49+8.76%$1.69$1.38627,591 shs$94.31 million Related Companies KROS Stock Price Chart TLRY Stock Price Chart MNMD Stock Price Chart ORGO Stock Price Chart ZVRA Stock Price Chart TYRA Stock Price Chart TSHA Stock Price Chart OPT Stock Price Chart BCYC Stock Price Chart KURA Stock Price Chart Receive GALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GALT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galectin Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galectin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
